RECRUITING

Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)

Talk to us

Conditions

Breast CancerBlack WomenBreast Cancer Survivor

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.

Official Title

Improving Communication and Adherence in Black Breast Cancer Survivors

Quick Facts

Study Start:2021-03-01
Study Completion:2025-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05334732

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Self-identify as Black
  2. * Newly diagnosed (\~4 weeks post-definitive surgery and prior to initiation of adjuvant chemotherapy or endocrine therapy) patients (stage I-III)
  3. * Eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy
  4. * Ability to read and speak English
  5. * Ability to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team
  6. * No prior cancer treatment (other than skin cancer) in the two years preceding enrollment
  7. * Physicians Must be a license doctor of study patient(s)
  8. * Ability to speak English
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Vanessa B Sheppard, Ph.D
CONTACT
804-682-2700
vanessa.sheppard@vcuhealth.org
Yvonne D Cummings, BS
CONTACT
804-828-0643
yvonne.cummings@vcuhealth.org

Principal Investigator

Vanessa B Sheppard, Ph.D
PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University

Study Locations (Sites)

Medstar Georgetown University Hospital
Washington, District of Columbia, 20007
United States
Massey Cancer Center
Richmond, Virginia, 23298
United States

Collaborators and Investigators

Sponsor: Virginia Commonwealth University

  • Vanessa B Sheppard, Ph.D, PRINCIPAL_INVESTIGATOR, Virginia Commonwealth University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-03-01
Study Completion Date2025-01-31

Study Record Updates

Study Start Date2021-03-01
Study Completion Date2025-01-31

Terms related to this study

Keywords Provided by Researchers

  • Breast Cancer
  • Black Women
  • Breast Cancer Survivor

Additional Relevant MeSH Terms

  • Breast Cancer